Device Trial Radar · NCT02187549
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
Last checked: Nov 19, 2026Latest source record: Oct 5, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
332
Planned (sponsor's estimate)
Start
Jun 2014
Primary completion
Feb 2016
Study completion Mar 2016
Sponsor
- Lead sponsor
- Fidia Farmaceutici s.p.a.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 11, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.
Conditions
- Knee Osteoarthritis
Interventions
HYMOVISDevice
Intra-articular injection
PlaceboDevice
Intra-Articular Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-scoreTime frame: 26 weeks
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Achieve Clinical Research
Birmingham, Alabama
Alabama Clinical Therapeutics
Brimingham, Alabama
Elite Clinical Studies
Phoenix, Arizona
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.